Apremilast

Price	$2000
Package	1KG

Product Details

Product Name: Apremilast	CAS No.: 608141-41-9
EC-No.: 1308068-626-2	Min. Order: 1KG
Purity: 98%	Supply Ability: 10kg
Release date: 2019/07/06

Ada

ApreMilast Usage And Synthesis

Description	Apremilast (Otezla) was approved by the FDA on March 21, 2014 for the treatment of adult patients with active psoriatic arthritis. Apremilast is a member of a new class of oral small molecule inhibitors of the phosphosphodiesterase 4 (PDE4) enzyme. When PDE4 is inhibited in immune cells, it results in elevation of intracellular cyclic adenosine monophosphate (cAMP) levels, which can regulate inflammatory mediators. The current clinical data indicate that apremilast is an effective and well tolerated option for the management of psoriasis and PsA in adults.
Uses	Treating active psoriatic arthritis. It is also used to treat moderate to severe plaque psoriasis in certain patients.
Metabolism and Drug interaction	Oral administration of apremilast has an absolute biovailability of 73% with peak concentration at 2.5 hours (Tmax). The half-life of apremilast is 6-9 hours. Apremilast is metabolized by the both cytochrome (CYP) and non-CYP pathways. In vitro studies have demonstrated that apremilast metabolism is primarily mediated by the CYP3A4 pathway. Thus, concomitant use of apremilast with CYP450 enzyme inducers (such as rifampin, phenobarbital, carbamazepine, phenytoin) is not recommended. There are no significant drug-drug interactions with oral contraceptives, ketoconazole, or methotrexate.
safety information	1.Apremilast may cause depression. The risk may be greater in patients who have a history of depression or suicidal thoughts or actions. Families and caregivers must closely watch patients who take apremilast. It is important to keep in close contact with the patient's doctor. Tell the doctor right away if the patient has new, worsened, or sudden symptoms, such as depression; anxiety, restlessness, or irritability; panic attacks; or any changes in behavior. Contact the doctor right away if any signs of suicidal thoughts or actions occur. 2.Apremilast may cause weight loss. You will need to have regular weight checks while you are taking apremilast.
side effects	Diarrhea; headache; nausea; weight loss.
References	1. http://www.rheumatology.org/Learning-Center/Publications-Communications/Drug-Safety/Hotline-Apremilast-for-the-Treatment-of-Psoriatic-Arthritis 2. https://www.ncbi.nlm.nih.gov/pubmed/26220911 3. https://www.drugs.com/cdi/apremilast.html 4. http://reference.medscape.com/drug/otezla-apremilast-999915
Definition	ChEBI: A member of the class of isoindoles that is isoindole-1,3-dione substituted at position 4 by an acetamido group and at position 1 by a 1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl group. Used for treatment of psoriatic arthritis.

Company Profile Introduction

Established in 2014,Career Henan Chemical Co. is a manufacturerspecializing in the sale of fine chemicals. Mainly deals in the sales of: Pharmaceutical intermediates OLED intermediates： Pharmaceutical intermediates; OLED intermediates;

Recommended supplier

Product name	Price		Suppliers	Update time
Apremilast	$980.00/1ton	VIP1Y	HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD	2024-08-15
Apremilast	$0.00/25kg	VIP1Y	PUSHAN INDUSTRIAL (SHAANXI) CO.,LTD	2024-05-17
Apremilast	$10.00/1kg		Ouhuang Engineering Materials (Hubei) Co., Ltd	2024-04-22
Apremilast	$200.00/1KG	VIP1Y	Henan Fengda Chemical Co., Ltd	2024-01-02
Apremilast	$0.00/1g	VIP2Y	shandong perfect biotechnology co.ltd	2023-08-14
Apremilast	$0.00/1KG	VIP2Y	Hangzhou ICH Biofarm Co., Ltd	2023-07-17
Apremilast	$0.00/25KG	VIP5Y	Hebei Mojin Biotechnology Co., Ltd	2023-06-26
Apremilast	$0.00/1kg	VIP3Y	Changzhou Rokechem Technology Co., Ltd.	2023-05-10
Apremilast	$200.00/1kg		Hebei Mingeng Biotechnology Co., Ltd	2022-11-20
Apremilast	$0.00/1KG	VIP3Y	Henan Aochuang Chemical Co.,Ltd.	2022-09-16

Product Details

Company Profile Introduction

You may like

Recommended supplier

career henan chemical co